Marc Tischkowitz

35.5k citations
160 papers · 7.5k · 4 hit papers · h-index 43

Impact in

  • Genetics top 0.2%
    • BRCA gene mutations in cancer
    • Genomics and Rare Diseases
    • Cancer Genomics and Diagnostics

Papers in

    • BRCA gene mutations in cancer 66
    • Genomic variations and chromosomal abnormalities 10
    • Genomics and Rare Diseases 6
    • DNA Repair Mechanisms 36
    • CRISPR and Genetic Engineering 7

Marc Tischkowitz

151 papers receiving 7.3k citations

Marc Tischkowitz's Hit Papers

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline 2024 · 78 citations
780+5+10Years since publication250500750

Peers

Marc Tischkowitz
Comparison fields: 5 of 135
  • Genetics 3.0k
  • Cancer Research 1.4k
  • Oncology 2.0k
  • Pathology and Forensic Medicine 914
  • Reproductive Medicine 389
Replace Amanda B. Spurdle with:
Amanda B. Spurdle Australia
Jeffrey N. Weitzel United States
Dominique Stoppa‐Lyonnet France
Georgia Chenevix‐Trench Australia
Diana Eccles United Kingdom
Judith Balmañà Spain
Marc S. Greenblatt United States
Barbara L. Weber United States
Gillian Mitchell Australia
Nadine Tung United States
Marc Tischkowitz relative to Amanda B. Spurdle Australia Amanda B. Spurdle's profile →
Citations per field
00.5×1.5×1.9×
Amanda B. Spurdle · 1×
Citations per year

Countries citing papers authored by Marc Tischkowitz

Since Specialization
Citations

This map shows the geographic impact of Marc Tischkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Tischkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Tischkowitz more than expected).

Fields of papers citing papers by Marc Tischkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Tischkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Tischkowitz. The network helps show where Marc Tischkowitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Tischkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Tischkowitz Line = papers co-authored together Marc Tischkowitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Hit paper breakdown →
2011855
2
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Hit paper breakdown →
2015582
3 2006456
4 2003431
5
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
Hit paper breakdown →
2019403
6 2007304
7 2008224
8 2003186
9 2007162
10 2000152
11 2010143
12 2011143
13 2022114
14 2017110
15 2007108
16 2004102
17 2012101
18 202093
19 201089
20
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Hit paper breakdown →
202478

About Marc Tischkowitz

Marc Tischkowitz is a scholar working on Genetics, Molecular Biology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 160 papers that have together received 7.5k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (66 papers), DNA Repair Mechanisms (36 papers), Genetic factors in colorectal cancer (16 papers), Cancer Genomics and Diagnostics (14 papers), Genomic variations and chromosomal abnormalities (10 papers), PARP inhibition in cancer therapy (8 papers), CRISPR and Genetic Engineering (7 papers) and Genomics and Rare Diseases (6 papers). The work is most often cited by research in Genetics (3.0k citations), Cancer Research (1.4k citations), Oncology (2.0k citations), Pathology and Forensic Medicine (914 citations) and Reproductive Medicine (389 citations). Marc Tischkowitz has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include William D. Foulkes, David G. Huntsman, Antonis C. Antoniou, Christopher G. Mathew, Douglas F. Easton, Bing Xia, Philippe M. Campeau, Katherine Schon, Paul D.P. Pharoah and André Robidoux. Their work appears in journals such as Journal of Medical Genetics, British Journal of Cancer, Genetics in Medicine, Journal of Clinical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact